Medical News

RSS

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.

30 Jan 2010

Surgeon General's report lays out recommendations to address childhood obesity

"As many as one in three children are overweight or obese, according to a new report" released yesterday by U.S. Surgeon General Regina Benjamin.

30 Jan 2010

Docking algorithm EADock allows successful design of new inhibitors for anti-cancer target

Many human tumors express indoleamine 2,3-dioxygenase (IDO), an enzyme which mediates an immune-escape in several cancer types. Researchers in the Molecular Modeling group at the SIB Swiss Institute of Bioinformatics and Dr. Beno-t J. Van den Eynde's group at the Ludwig Institute for Cancer Research Ltd (LICR) Brussels Branch developed an approach for creating new IDO inhibitors by computer-assisted structure-based drug design. The study was presented in the January 2010 online issue of the Journal of Medicinal Chemistry.

30 Jan 2010

New study identifies that SynDIG1 plays critical role in creating and sustaining synapses

A new study from UC Davis Health System identifies for the first time a brain protein called SynDIG1 that plays a critical role in creating and sustaining synapses, the complex chemical signaling system responsible for communication between neurons.

30 Jan 2010

Texas colleges readying students to build, maintain electronic medical records

Three central Texas colleges are applying for a federal grant to train students in the use of electronic medical records, The Texas Tribune reports. "Texas State University in San Marcos and the University of Texas at Austin are partnering with the University of Texas School of Health Information in Houston to apply for a new federal grant in health information that could bring in $6 million across the three campuses.

30 Jan 2010

Vanguard Health Systems closes $950M 8% Senior Notes offering

Vanguard Health Systems, Inc. ("Vanguard") announced the closing today of the private placement offering of $950.0 million aggregate principal amount of 8% Senior Notes due 2018 (the "Notes") co-issued by Vanguard's subsidiaries, Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Holding Company II, Inc. ("VHS Holdco II Inc." and, together with VHS Holdco II, the "Issuers").

30 Jan 2010

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable more comprehensive genetic analysis of clinical and research samples, announced today that it has reached agreement with ZyGEM to non-exclusively market Rubicon's PicoPlex™ single-cell amplification kits in Australia and New Zealand.

30 Jan 2010

Republicans tout alternative health care reform plans, react to Dems

Following President Barack Obama's challenge to "let me know" if they had better ideas for a health overhaul, Rep. John Boehner, the House Republican leader, said that their plan, rejected last November by the Democratic majority in the House, would satisfy Obama's goals to "bring down premiums, bring down the deficit, cover the uninsured" and improve Medicare, BusinessWeek reports. "The Republican ideas ... may have a bigger role in defining party differences this election year than in crafting a compromise on the health bill. That's because the gap between the two approaches is so wide."

30 Jan 2010

Healthcare Services Group declares cash dividend

Healthcare Services Group, Inc.: Our Board of Directors has declared a regular quarterly cash dividend of $ .21 per common share, payable on March 5, 2010 to shareholders of record at the close of business February 12, 2010. This dividend represents a 5% increase over the dividend declared for the 2009 third quarter and a 24% increase over the 2008 same period payment.

30 Jan 2010

$Study shows hip fractures in elderly men are linked to impaired bone health in their grandsons$

Study shows hip fractures in elderly men are linked to impaired bone health in their grandsons

If your grandfather has had a hip fracture, you too could be at risk. Researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have been able to show, for the first time, a link between hip fractures in elderly men and impaired bone health in their grandsons.

30 Jan 2010

Obama, Republicans face off on a range of issues including health reform

Politico: "President Barack Obama told House Republicans Friday that Washington can't break through partisan gridlock 'if we can't move past the politics of no' — then engaged with them in an extraordinary back-and-forth straight out of the House of Commons."

30 Jan 2010

White House wants to scale up war on Medicare fraud

The White House plans to ask Congress to increase funding for fighting Medicare fraud by 80 percent, in hopes of curbing billions of dollars in abuses, Dow Jones Newswires/NASDAQ reports. Already, "The administration has stepped up enforcement and prevention efforts targeting Medicare claims. Rather than rely on tips, it has begun combining Medicare claims data into a single, searchable database, making it easier to pinpoint suspicious claims among the more than $1 billion spent on such claims each day" (Burns, 1/28).

30 Jan 2010

BG Medicine files registration statement with SEC for proposed initial public offering of common stock

BG Medicine, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range of the offering have not yet been determined.

30 Jan 2010

Gilead Sciences' board authorizes share repurchase program

Gilead Sciences, Inc. today announced that the company’s Board of Directors has authorized the repurchase of up to $1.0 billion of the company’s common stock through January 2011.

30 Jan 2010

Dental hygienists provide free oral care services for Valentine's Day

To honour the spirit of Valentine's Day, on February 13 registered dental hygienists across the province will provide oral care services to the public at no cost.

30 Jan 2010

NuVasive reports preliminary unaudited financial results for full year ended December 31, 2009

NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for the full year ended December 31, 2009.

30 Jan 2010

Government cracks down on drug marketing

Recent crackdown on pharmaceutical companies suggests that drug marketing remains an issue with federal authorities. The Wall Street Journal reports: "Novartis AG's agreement to settle criminal allegations involving marketing of an epilepsy drug is the latest in a string of cases showing that improper marketing practices are still a problem years after the U.S. government started cracking down on them.

30 Jan 2010

Study shows majority of patients gain weight after knee replacement surgery

You'd think folks who've had knee replacement surgery -- finally able to walk and exercise without pain -- would lose weight instead of put on pounds, but surprisingly that's not the case, according to a University of Delaware study.

30 Jan 2010

Pelosi, Reid search for health reform's forward path

Legislative leaders in search of momentum on health reform "conceded that they did not have an immediate strategy for advancing a health care measure and described their time frame as open-ended," The New York Times reports.

30 Jan 2010

Mylan's subsidiary receives FDA approval for GoLytely laxative

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 and Electrolytes for Oral Solution, USP, the generic version of Braintree Laboratories' GoLytely® laxative.

30 Jan 2010

Medical News

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

Surgeon General's report lays out recommendations to address childhood obesity

Docking algorithm EADock allows successful design of new inhibitors for anti-cancer target

New study identifies that SynDIG1 plays critical role in creating and sustaining synapses

Texas colleges readying students to build, maintain electronic medical records

Vanguard Health Systems closes $950M 8% Senior Notes offering

Rubicon Genomics reaches agreement with ZyGEM to market its PicoPlex single-cell amplification kits

Republicans tout alternative health care reform plans, react to Dems

Healthcare Services Group declares cash dividend

Study shows hip fractures in elderly men are linked to impaired bone health in their grandsons

Obama, Republicans face off on a range of issues including health reform

White House wants to scale up war on Medicare fraud

BG Medicine files registration statement with SEC for proposed initial public offering of common stock

Gilead Sciences' board authorizes share repurchase program

Dental hygienists provide free oral care services for Valentine's Day

NuVasive reports preliminary unaudited financial results for full year ended December 31, 2009

Government cracks down on drug marketing

Study shows majority of patients gain weight after knee replacement surgery

Pelosi, Reid search for health reform's forward path

Mylan's subsidiary receives FDA approval for GoLytely laxative

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News